Thomas Thomaidis

2PUBLICATIONS
1CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 06, 2021
CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset.

Annett Maderer, Frederic Fiteni, Erik Tanis

|Jan 13, 2019
Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program.

Markus Moehler, Annett Maderer, Anne Ehrlich

Pageof 1

Frequent Collaborators

1 joint publications

Manfred P Lutz